Clinical Trial Update: Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit

View source ↗

Summary

A completed clinical trial evaluating the efficacy and safety of starting Bictegravir/Emtricitabine/Tenofovir alafenamide as first-line ART at the initial HIV c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: University Hospital for Infectious Diseases, Croatia | Conditions: HIV Infections | Status: COMPLETED